China-based molecular diagnostics specialist Sansure Biotech Inc. (SHA: 688289) has announced a strategic partnership with Hunan Normal University. The collaboration aims to leverage the respective strengths of both entities to delve deeper into talent cultivation, scientific research, and platform co-construction, among other areas. No financial details of the partnership were disclosed.
Sansure’s Global Presence
Sansure, a leading molecular diagnostics company, has established three major industry bases in Changsha, Shanghai, and Beijing. The company has also expanded its operations to major cities in the US, France, Indonesia, the Philippines, and more. This global presence positions Sansure to effectively collaborate with academic and research institutions, enhancing its capabilities in molecular diagnostics and related fields.
Collaboration Objectives
The partnership with Hunan Normal University is expected to foster a collaborative environment that promotes innovation and the development of new technologies in molecular diagnostics. By combining Sansure’s industry expertise with the university’s research capabilities, the collaboration aims to accelerate the translation of scientific discoveries into practical applications, ultimately benefiting patients and healthcare providers.-Fineline Info & Tech
